TBMED aims to develop an Open Innovation Test Bed (OITB) for high risk medical devices that provides a single entry point to services along the whole value chain from preclinical development to clinical testing. The entire development will be based on a Quality-by-Design (QbD) concept.

TBMED aims to support med-tech companies in the development of high-risk medical devices by reducing their time-to-market for the European sector.

TBMED will help European SMEs to maintain their competitiveness and innovation capacity in the face of global competition, e.g. from larger providers. Its aim is to minimize time-to-market and efforts for reimbursement and make medical devices accessible to patients more easily.

Upcoming events

CLINAM 2020

October 25, 2020 — October 28, 2020
Basel, Switzerland

MEDICA 2020

November 16, 2020 — November 19, 2020
Dusseldorf, Germany

Facts and Figures

4 years
Duration

4 years

4 Countries
13 Partners

4 Countries

8.5 M €
Funding

8.5 M €

Consortium